Experience

    • A major investor in Envigo, a pharmaceutical and biotechnology research provider, in the financing aspects of the sale of Envigo to Inotiv, a drug discovery and development contract research organization, for a total transaction value of approximately $545 million.
    • Post Advisory Group in the documentation of loan swap transactions with Bank of America and Deutsche Bank.

Education

  • Harvard Law School, 1996, J.D.
  • University of Pennsylvania, 1992, B.A.
  • University of Pennsylvania, 1992, B.S.